Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1989-2-13
|
pubmed:abstractText |
We have measured the plasma levels of somatomedin-C (SM-C) or insulin-like growth factor I (IGF-I) in 13 patients with progressive systemic sclerosis (PSS) and age and sex matched healthy controls. We found the plasma SM-C levels to be within normal limits in all the patients. Thus, if somatomedin-C plays a role in the pathogenesis of PSS, it is more likely to be at the fibroblast receptor level or in the synthetic response of fibroblasts to SM-C.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0007-0963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
639-42
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3207616-Adult,
pubmed-meshheading:3207616-Aged,
pubmed-meshheading:3207616-Female,
pubmed-meshheading:3207616-Humans,
pubmed-meshheading:3207616-Insulin-Like Growth Factor I,
pubmed-meshheading:3207616-Male,
pubmed-meshheading:3207616-Middle Aged,
pubmed-meshheading:3207616-Scleroderma, Systemic,
pubmed-meshheading:3207616-Somatomedins
|
pubmed:year |
1988
|
pubmed:articleTitle |
Plasma somatomedin-C levels in systemic sclerosis.
|
pubmed:affiliation |
Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Florida 33101.
|
pubmed:publicationType |
Journal Article
|